Position in GSK
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$43,968,266
-$632,921 QoQ
Shares Held
838,769
+3.8% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#50
of 1,033 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 94%
Shared 5%
None 1%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $24,361,895,957 across 16 Drug Manufacturers - General names. GSK ranks #12 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,783,459 | $5,737,424,695 | |
| 2 | JNJ |
Johnson & Johnson
|
21,683,347 | $5,506,919,623 | |
| 3 | ABBV |
AbbVie Inc.
|
12,853,368 | $3,234,421,512 | |
| 4 | MRK |
Merck & Co., Inc.
|
18,340,173 | $2,356,712,224 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
15,263,929 | $1,928,444,775 | |
| 6 | PFE |
Pfizer Inc
|
57,879,546 | $1,393,739,453 | |
| 7 | AMGN |
Amgen Inc
|
3,695,586 | $1,338,245,590 | |
| 8 | AZN |
Astrazeneca PLC
|
6,753,962 | $1,280,686,266 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43,968,266 | 838,769 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $44,601,187 | 808,139 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $45,979,310 | 937,588 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $44,463,471 | 1,030,201 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $38,011,080 | 989,872 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $40,740,411 | 1,051,637 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $32,942,401 | 974,051 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $38,974,662 | 953,392 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $35,670,904 | 926,517 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $36,733,928 | 856,868 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $33,221,210 | 896,417 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $33,991,223 | 937,689 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $33,916,982 | 951,655 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $35,499,194 | 997,729 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $36,370,670 | 1,035,022 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $30,359,925 | 1,031,598 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $50,281,027 | 1,177,701 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $49,609,885 | 1,161,181 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $54,962,502 | 1,270,713 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $57,170,382 | 1,525,505 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $47,201,562 | 1,208,578 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $43,024,408 | 1,229,102 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $46,718,840 | 1,294,386 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $54,334,748 | 1,471,796 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $60,898,436 | 1,522,201 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $65,391,152 | 1,759,600 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||